VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017

Feb 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-02-03

Reporting Person: Silva Paul M (SVP & Corp Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-03	Common Stock	A	6321	$0.00	Acquired	20071	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-03	Stock Option (Right to Buy)	$86.52	A	12944	Acquired	2027-02-02	Common Stock (12944)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	169	Indirect

Footnotes

F1: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020.

F2: The option vests in 16 quarterly installments from 02/03/2017.